Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis of a potent Small-Molecule immunomodulator

ABSTRACT: Transcriptome analysis of a potent Small-Molecule immunomodulator

PROVIDER: PRJNA931296 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23333204_1.fastq.gz	Fastqsanger.gz
	SRR23333204_2.fastq.gz	Fastqsanger.gz
	SRR23333205_1.fastq.gz	Fastqsanger.gz
	SRR23333205_2.fastq.gz	Fastqsanger.gz
	SRR23333206_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Transcriptome analysis of high potent DCs using small molecule compounds

Project description:Transcriptome analysis of high potent DCs using small molecule compounds

| PRJNA998841 | ENA

Transcriptome analysis of a potent Small-Molecule immunomodulator

Project description:To elucidate the signalling pathways that result in activation of PBMCs following the addition of Compound B

2024-02-03 | GSE224468 | GEO

Transcriptome analysis of high potent DCs using small molecule compounds

Project description:Comparative gene expression analysis of generated DCs on several condition with small molecule compounds

2023-10-02 | GSE239334 | GEO

New, Potent, Small Molecule Agonists of Tyrosine Kinase Receptors Improve Dry Eye Disease

Project description:New, Potent, Small Molecule Agonists of Tyrosine Kinase Receptors Improve Dry Eye Disease

| PRJNA835818 | ENA

A potent and selective small-molecule degrader of ENL suppresses leukemia progression in vivo

Project description:A potent and selective small-molecule degrader of ENL suppresses leukemia progression in vivo

| PRJNA1030395 | ENA

Chimeric exosomes-derived immunomodulator restoring lymph node microenvironment for sensitizing TNBC immunotherapy

Project description:Immunotherapy is a breakthrough in the treatment of triple-negative breast cancer (TNBC), whereas is effective in a portion of patients. Our clinical studies found that lipid homeostasis imbalance and dendritic cells (DCs) dysfunction contributed to the immunosuppressive microenvironment in the lymph nodes (LNs) of TNBC patients following immunotherapy, which greatly affected the immunotherapeutic efficacy. Building on this, we introduce a chimeric exosomes-derived immunomodulator, EMV@SS-Toy, involving a polysulfide bond-bridged mesoporous silica nanoparticles (SS-MSN) as a reactive oxygen species (ROS) scavenger and responsive carrier nucleus, loading with the (IRE1α-XBP1) inhibitor toyocamycin (Toy) and coating with chimeric exosomes comprising DCs-derived exosomes and Salmonella outer membrane vesicles. This multifaceted immunomodulator can significantly enhance LNs’ homing via homologous targeting and chemokine-guided navigation, enabling a pathological ROS-responsive drug release, dual-stress pathway regulation, thereby restoring and DCs’ function and LNs’ immune microenvironment. As expected, the immunomodulator markedly boosted the responsiveness of TNBC to immunotherapy, exerting potent inhibition on both the primary tumor and metastases and establishing long-term immune surveillance. Our study provides potent directions for translational immunotherapy through optimizing the LNs’ microenvironment in TNBC.

2024-10-01 | GSE270025 | GEO

A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo

Project description:A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo

| PRJNA543332 | ENA

A Potent and Selective Small-Molecule STAT5 PROTAC Degrader Capable of Achieving Tumor Regression In Vivo

Project description:We have developed AK2292 as a first, potent and selective small-molecule degrader of both STAT5A and STAT5B isoforms. To investigate the effect of STAT5A/STAT5B depletion on the transcriptome, we treated KU812 and NCO2 cells with AK2292 at 1 μM for 8 h and performed RNA-seq analysis. As a control, we treated KU812 and NCO2 cells with AK2292Me at 5 μM for 24 h for RNA-seq analysis. RNA-seq analysis revealed that AK2292 downregulates the transcriptome associated with STAT5A and STAT5B.

2022-12-15 | GSE217647 | GEO

Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming

Project description:Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming

| PRJNA506035 | ENA

A potent and selective small-molecule degrader of ENL suppresses leukemia progression in vivo (ChIP-Seq)

Project description:A potent and selective small-molecule degrader of ENL suppresses leukemia progression in vivo (ChIP-Seq)

| PRJNA1030399 | ENA